Td Asset Management Inc Vir Biotechnology, Inc. Transaction History

Td Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$23.2 - $27.29 $663,520 - $780,494	28,600 New	28,600 $701,000
Q2 2022 Aug 04, 2022	SELL	$19.08 - $26.7 $408,311 - $571,380	-21,400 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$21.19 - $40.01 $404,729 - $764,191	-19,100 Reduced 47.16%	21,400 $550,000
Q4 2021 Feb 10, 2022	BUY	$30.97 - $54.03 $1.25 Million - $2.19 Million	40,500 New	40,500 $1.7 Million

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $979M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.